Menu
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

EQS-News: Linde Announces First Quarter 2023 Earnings and Conference Call Schedule
EQS-News: Linde Announces First Quarter 2023 Earnings and Conference Call Schedule
EQS-News: Linde Announces First Quarter 2023 Earnings and Conference Call Schedule
EQS-News: Deutsche Postbank Funding Trust I: Preliminary announcement on the publication of financial reports pursuant to Sections 114, 115, 117 WpHG​​​​​​​
EQS-News: Deutsche Postbank Funding Trust I: Preliminary announcement on the publication of financial reports pursuant to Sections 114, 115, 117 WpHG​​​​​​​
EQS-News: Deutsche Postbank Funding Trust I: Preliminary announcement on the publication of financial reports pursuant to Sections 114, 115, 117 WpHG​​​​​​​
Interroll - new Managing Director for SingaporePhoto, wide shot, wide-angle lens,  Construction equipment, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://img.midjourneyapi.xyz/temp/96af5505-e3c8-4496-bbb7-e4a5eba91e77.png
Interroll - new Managing Director for Singapore
Interroll - new Managing Director for Singapore
EQS-News: CPI PROPERTY GROUP – Tender Offer Results
EQS-News: CPI PROPERTY GROUP – Tender Offer Results
EQS-News: CPI PROPERTY GROUP – Tender Offer Results
Cairn Homes Plc: Transaction in Own SharesPhoto, wide shot, wide-angle lens,  Home appliance manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/5d70b6df-fa9b-4237-9702-39c36cb1d4f8.png
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
Samarkand Group plc : Trading Update
Samarkand Group plc : Trading Update
Samarkand Group plc : Trading Update
Director DeclarationPhoto, wide shot, wide-angle lens,  Logistics company, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/a16a79c7-f73c-405d-ba63-e8d69b66ce4e.png
Director Declaration
Director Declaration
Unaudited NAV for March 2023
Unaudited NAV for March 2023
Unaudited NAV for March 2023
AGM Update - the I-RES Board unanimously recommends shareholders vote FOR all proposed resolutions at the 2023 AGM
AGM Update - the I-RES Board unanimously recommends shareholders vote FOR all proposed resolutions at the 2023 AGM
AGM Update - the I-RES Board unanimously recommends shareholders vote FOR all proposed resolutions at the 2023 AGM
EQS-News: Defence Therapeutics Inc.: DEFENCE'S NOVEL ACCUMTM-mRNA VACCINE NOW ADMINISTERED FOR TESTING ON CANCER
EQS-News: Defence Therapeutics Inc.: DEFENCE'S NOVEL ACCUMTM-mRNA VACCINE NOW ADMINISTERED FOR TESTING ON CANCER
EQS-News: Defence Therapeutics Inc.: DEFENCE'S NOVEL ACCUMTM-mRNA VACCINE NOW ADMINISTERED FOR TESTING ON CANCER
Cicor achieves sales growth of 24.8% in the first quarter of 2023Photo, wide shot, wide-angle lens, soft focus,  Networking equipment supplier, sunset photo at golden hour, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-LvyAFCAMshu3rGBke5G5gxuI.png?st=2023-05-10T15%3A37%3A29Z&se=2023-05-10T17%3A37%3A29Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-10T02%3A36%3A27Z&ske=2023-05-11T02%3A36%3A27Z&sks=b&skv=2021-08-06&sig=nXxCmLby4SxAAd/YtNVxZStdXrs9BCydapQDQaR/oac%3D
Cicor achieves sales growth of 24.8% in the first quarter of 2023
Cicor achieves sales growth of 24.8% in the first quarter of 2023
Relief Therapeutics Announces Positive 12-Month Stability Data for Inhaled and Intravenous Preparations of RLF-100Photo, wide shot, wide-angle lens, soft focus,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-d5U47McddROtnUwv1JIaZvc2.png?st=2023-05-04T16%3A11%3A57Z&se=2023-05-04T18%3A11%3A57Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T16%3A04%3A37Z&ske=2023-05-05T16%3A04%3A37Z&sks=b&skv=2021-08-06&sig=KvGLXJQj4L2uYw31IYBsPpHX4telRq/7natMW2uEF58%3D
Relief Therapeutics Announces Positive 12-Month Stability Data for Inhaled and Intravenous Preparations of RLF-100
Relief Therapeutics Announces Positive 12-Month Stability Data for Inhaled and Intravenous Preparations of RLF-100
Sales for the first quarter 2023

Ad hoc announcement pursuant to Art. 53 LRPhoto, wide shot, wide-angle lens,  Metal fabrication, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.midjourneyapi.xyz/temp/138548fd-aba2-4b3e-b9ee-93725b372952.png
Sales for the first quarter 2023 Ad hoc announcement pursuant to Art. 53 LR
Sales for the first quarter 2023 Ad hoc announcement pursuant to Art. 53 LR
EQS-News: MorphoSys and Incyte Announce Five-Year Results of L-MIND Study Showed Prolonged, Durable Responses in Relapsed or Refractory DLBCL Patients Treated with Monjuvi® (tafasitamab-cxix)Photo, wide shot, wide-angle lens, soft focus,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-pKgbwxVSbyTCu0UzPNe8NL8D.png?st=2023-05-04T16%3A02%3A58Z&se=2023-05-04T18%3A02%3A58Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T12%3A13%3A51Z&ske=2023-05-05T12%3A13%3A51Z&sks=b&skv=2021-08-06&sig=%2BhYssNp3W0HiZMxCV64XVELyP8stYUjFhgUVfPrTLyg%3D
EQS-News: MorphoSys and Incyte Announce Five-Year Results of L-MIND Study Showed Prolonged, Durable Responses in Relapsed or Refractory DLBCL Patients Treated with Monjuvi® (tafasitamab-cxix)
EQS-News: MorphoSys and Incyte Announce Five-Year Results of L-MIND Study Showed Prolonged, Durable Responses in Relapsed or Refractory DLBCL Patients Treated with Monjuvi® (tafasitamab-cxix)
EQS-Adhoc: TRATON SE announces preliminary 3M 2023 results
EQS-Adhoc: TRATON SE announces preliminary 3M 2023 results
EQS-Adhoc: TRATON SE announces preliminary 3M 2023 results
Cairn Homes Plc: Holding(s) in CompanyPhoto, wide shot, wide-angle lens,  Clothing manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Marc Adamus: https://img.midjourneyapi.xyz/temp/7d69264d-49b2-466c-9987-b2706836d522.png
Cairn Homes Plc: Holding(s) in Company
Cairn Homes Plc: Holding(s) in Company
GEVELOT S.A.: PRESS RELEASE CLOSING OF 2022 ACCOUNTSPhoto, wide shot, wide-angle lens,  Aerospace components, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/3938f51e-9b01-45a9-aed1-ff9d047063fc.png
GEVELOT S.A.: PRESS RELEASE CLOSING OF 2022 ACCOUNTS
GEVELOT S.A.: PRESS RELEASE CLOSING OF 2022 ACCOUNTS
Rights and Issues Investment Trust PLC: POS-Transaction in Own SharesPhoto, wide shot, wide-angle lens,  Private equity firm, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://img.theapi.app/temp/2b695cca-48cb-4195-802a-e3385fb90ec0.png
Rights and Issues Investment Trust PLC: POS-Transaction in Own Shares
Rights and Issues Investment Trust PLC: POS-Transaction in Own Shares
NORNICKEL DISCONTINUES DISCLOSURE VIA PRIMARY INFORMATION PROVIDERPhoto, wide shot, wide-angle lens,  Gold mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/94faf2bd-99c1-4ea6-b55d-fdcab23c3865.png
NORNICKEL DISCONTINUES DISCLOSURE VIA PRIMARY INFORMATION PROVIDER
NORNICKEL DISCONTINUES DISCLOSURE VIA PRIMARY INFORMATION PROVIDER
EQS-News: Nagarro releases audited financial results for 2022, announces share buyback: https://upload.wikimedia.org/wikipedia/commons/0/0a/Nagarro_Horizontal_Light_400x100px_300dpi.png
EQS-News: Nagarro releases audited financial results for 2022, announces share buyback
EQS-News: Nagarro releases audited financial results for 2022, announces share buyback
EQS-Adhoc: Management Board of Nagarro SE resolves on share buyback program with a volume of up to 30 million euros: https://upload.wikimedia.org/wikipedia/commons/0/0a/Nagarro_Horizontal_Light_400x100px_300dpi.png
EQS-Adhoc: Management Board of Nagarro SE resolves on share buyback program with a volume of up to 30 million euros
EQS-Adhoc: Management Board of Nagarro SE resolves on share buyback program with a volume of up to 30 million euros
Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)Photo, wide shot, wide-angle lens,  Private equity firm, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://img.theapi.app/temp/2b695cca-48cb-4195-802a-e3385fb90ec0.png
Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)
Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)
Hardman & Co Q&A on City of London Investment Group (CLIG): Continuing its good performancePhoto, wide shot, wide-angle lens,  Private equity firm, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://img.theapi.app/temp/2b695cca-48cb-4195-802a-e3385fb90ec0.png
Hardman & Co Q&A on City of London Investment Group (CLIG): Continuing its good performance
Hardman & Co Q&A on City of London Investment Group (CLIG): Continuing its good performance
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plcPhoto, wide shot, wide-angle lens, soft focus,  Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-News: IBU-tec advanced materials AG: Ulrich Weitz will not move to the Supervisory Board in 2023
EQS-News: IBU-tec advanced materials AG: Ulrich Weitz will not move to the Supervisory Board in 2023
EQS-News: IBU-tec advanced materials AG: Ulrich Weitz will not move to the Supervisory Board in 2023